#db03 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #db03, aggregated by home.social.
-
Happy to share our now published #DB03 update!
Trastuzumab deruxtecan versus TDM1 in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial - ScienceDirect https://www.sciencedirect.com/science/article/pii/S0140673622024205